Pavol Szomolanyi

Dr. Pavol Szomolanyi

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2009 in Medical Physics
Verified
Journal Article
Closed access
PDF file
Marius MayerhoeferMarius Mayerhoefer
Marius Mayerhoefer
PSPavol Szomolanyi
Pavol Szomolanyi
DJDaniel Jirák
Daniel Jirák
AMAndrzej Materka
Andrzej Materka
STSiegfried Trattnig
Siegfried Trattnig

27 June 2006 in European Radiology
Verified
Journal Article
Open access
PDF file
Siegfried TrattnigSiegfried Trattnig
Siegfried Trattnig
SMS. A. Millington
S. A. Millington
PSPavol Szomolanyi
Pavol Szomolanyi
SMS. Marlovits
S. Marlovits
Surgical articular cartilage repair therapies for cartilage defects such as osteochondral autograft transfer, autologous chondrocyte implantation (ACI) or matrix associated autologous chondrocyte transplantation (MACT) are becoming more common. MRI has become the method of choice for non-invasive follow-up of patients after cartilage repair surgery. It should be performed with cartilage sensitive sequences, including fat-suppressed proton density-weighted T2 fast spin-echo (PD/T2-FSE) and three-dimensional gradient-echo (3D GRE) sequences, which provide good signal-to-noise and contrast-to-noise ratios. A thorough magnetic resonance (MR)-based assessment of cartilage repair tissue includes evaluations of defect filling, the surface and structure of repair tissue, the signal intensity of repair tissue and the subchondral bone status. Furthermore, in osteochondral autografts surface congruity, osseous incorporation and the donor site should be assessed. High spatial resolution is mandatory and can be achieved either by using a surface coil with a 1.5-T scanner or with a knee coil at 3 T; it is particularly important for assessing graft morphology and integration. Moreover, MR imaging facilitates assessment of complications including periosteal hypertrophy, delamination, adhesions, surface incongruence and reactive changes such as effusions and synovitis. Ongoing developments include isotropic 3D sequences, for improved morphological analysis, and in vivo biochemical imaging such as dGEMRIC, T2 mapping and diffusion-weighted imaging, which make functional analysis of cartilage possible.

25 September 2007 in Journal of Magnetic Resonance Imaging
Verified
Journal Article
Open access
PDF file
Siegfried TrattnigSiegfried Trattnig
Siegfried Trattnig
SMStefan Marlovits
Stefan Marlovits
SGSimone Gebetsroither
Simone Gebetsroither
PSPavol Szomolanyi
Pavol Szomolanyi
GWGötz H. Welsch
Götz H. Welsch
TMTallal Charles Mamisch
Tallal Charles Mamisch
Purpose: To use a 3D gradient‐echo (GRE) sequence with two flip angles for delayed gadolinium‐enhanced MRI of cartilage (dGEMRIC) to evaluate relative glycosaminoglycan content of repair tissue after matrix‐associated autologous chondrocyte transplantation (MACT).Materials and Methods: In a phantom study, T1‐mapping based on a 3D‐GRE sequence with different flip angle combinations was compared with a standard inversion recovery (IR) sequence at 3.0T. Fifteen patients were examined after MACT in the knee at “3–13 months” (group I) and “19–42 months” (group II). The δ relaxation rate (δR1) calculated for repair tissue and normal hyaline cartilage was measured and mean values were compared in different postoperative intervals using analysis of variance.Results: The flip angle combination 35/10° provided the best agreement with IR sequence for short and long T1 values. The mean δR1 for repair tissue was 2.49 versus 1.04 at the intact control site in group I and 1.90 compared with 0.81 in group II. Differences from repair tissue to control sites showed statistically significance for both groups; no significant difference was found between groups.Conclusion: The 3D dual flip angle dGEMRIC technique optimized for cartilage imaging is comparable to standard T1 IR technique for T1 mapping. Furthermore, the preliminary in vivo study demonstrates the feasibility of the technique in the evaluation of MACT patients. J. Magn. Reson. Imaging 2007;26:974–982.

1 September 2008 in Investigative Radiology
Verified
Journal Article
Closed access
GWGötz H. Welsch
Götz H. Welsch
TMTallal C. Mamisch
Tallal C. Mamisch
THTimothy Hughes
Timothy Hughes
CZChristoph Zilkens
Christoph Zilkens
SQSebastian Quirbach
Sebastian Quirbach
STSiegfried Trattnig
Siegfried Trattnig
Ultra-high-field whole-body systems (7.0 T) have a high potential for future human in vivo magnetic resonance imaging (MRI). In musculoskeletal MRI, biochemical imaging of articular cartilage may benefit, in particular. Delayed gadolinium-enhanced MRI of cartilage (dGEMRIC) and T2 mapping have shown potential at 3.0 T. Although dGEMRIC, allows the determination of the glycosaminoglycan content of articular cartilage, T2 mapping is a promising tool for the evaluation of water and collagen content. In addition, the evaluation of zonal variation, based on tissue anisotropy, provides an indicator of the nature of cartilage ie, hyaline or hyaline-like articular cartilage. Thus, the aim of our study was to show the feasibility of in vivo dGEMRIC, and T2 and T2* relaxation measurements, at 7.0 T MRI; and to evaluate the potential of T2 and T2* measurements in an initial patient study after matrix-associated autologous chondrocyte transplantation (MACT) in the knee. MRI was performed on a whole-body 7.0 T MR scanner using a dedicated circular polarization knee coil. The protocol consisted of an inversion recovery sequence for dGEMRIC, a multiecho spin-echo sequence for standard T2 mapping, a gradient-echo sequence for T2* mapping and a morphologic PD SPACE sequence. Twelve healthy volunteers (mean age, 26.7 ± 3.4 years) and 4 patients (mean age, 38.0 ± 14.0 years) were enrolled 29.5 ± 15.1 months after MACT. For dGEMRIC, 5 healthy volunteers (mean age, 32.4 ± 11.2 years) were included. T1 maps were calculated using a nonlinear, 2-parameter, least squares fit analysis. Using a region-of-interest analysis, mean cartilage relaxation rate was determined as T1 (0) for precontrast measurements and T1 (Gd) for postcontrast gadopentate dimeglumine [Gd-DTPA(2-)] measurements. T2 and T2* maps were obtained using a pixelwise, monoexponential, non-negative least squares fit analysis; region-of-interest analysis was carried out for deep and superficial cartilage aspects. Statistical evaluation was performed by analyses of variance. Mean T1 (dGEMRIC) values for healthy volunteers showed slightly different results for femoral [T1 (0): 1259 ± 277 ms; T1 (Gd): 683 ± 141 ms] compared with tibial cartilage [T1 (0): 1093 ± 281 ms; T1 (Gd): 769 ± 150 ms]. Global mean T2 relaxation for healthy volunteers showed comparable results for femoral (T2: 56.3 ± 15.2 ms; T2*: 19.7 ± 6.4 ms) and patellar (T2: 54.6 ± 13.0 ms; T2*: 19.6 ± 5.2 ms) cartilage, but lower values for tibial cartilage (T2: 43.6 ± 8.5 ms; T2*: 16.6 ± 5.6 ms). All healthy cartilage sites showed a significant increase from deep to superficial cartilage (P < 0.001). Within healthy cartilage sites in MACT patients, adequate values could be found for T2 (56.6 ± 13.2 ms) and T2* (18.6 ± 5.3 ms), which also showed a significant stratification. Within cartilage repair tissue, global mean values showed no difference, with 55.9 ± 4.9 ms for T2 and 16.2 ± 6.3 ms for T2*. However, zonal assessment showed only a slight and not significant increase from deep to superficial cartilage (T2: P = 0.174; T2*: P = 0.150). In vivo T1 dGEMRIC assessment in healthy cartilage, and T2 and T2* mapping in healthy and reparative articular cartilage, seems to be possible at 7.0 T MRI. For T2 and T2*, zonal variation of articular cartilage could also be evaluated at 7.0 T. This zonal assessment of deep and superficial cartilage aspects shows promising results for the differentiation of healthy and affected articular cartilage. In future studies, optimized protocol selection, and sophisticated coil technology, together with increased signal at ultra-high-field MRI, may lead to advanced biochemical cartilage imaging.

1 August 2004 in Journal of Magnetic Resonance
Verified
Journal Article
Closed access
Vladimir MlynarikVladimir Mlynarik
Vladimir Mlynarik
PSPavol Szomolanyi
Pavol Szomolanyi
RTRenato Toffanin
Renato Toffanin
FVF Vittur
F Vittur
STS Trattnig
S Trattnig

1 September 2009 in Investigative Radiology
Verified
Journal Article
Closed access
Katja Pinker-DomenigKatja Pinker-Domenig
Katja Pinker-Domenig
GGGunther Grabner
Gunther Grabner
Wolfgang BognerWolfgang Bogner
Wolfgang Bogner
SGStephan Gruber
Stephan Gruber
PSPavol Szomolanyi
Pavol Szomolanyi
THThomas Helbich
Thomas Helbich
To develop a 3.0 Tesla breast imaging protocol that combines high temporal and spatial resolution three-dimensional MR sequences for quantitative time course and morphologic analysis of breast lesions. Thirty-four patients were included in the study (age range, 31–82; mean age, 54.3). The study protocol was approved by the Institutional Review Board and written informed consent was obtained from all patients. The magnetic resonance imaging protocol included: a coronal T1-weighted volume-interpolated-breathhold-examination sequence, focused on high temporal resolution for optimal assessment of the contrast-enhancement behavior of lesions (SI 1.7 mm isotropic; TA 3.45 minutes for 17 measurements); a coronal T1-weighted turbo fast-low-angle-shot-three-dimensional sequence, with water-excitation and fat suppression, focused on high spatial resolution for morphologic analysis (SI 1 mm isotropic; TA 2 minutes); and a repeated coronal volume-interpolated-breathhold-examination sequence for detection of washout. Lesion size and morphology were assessed. Region-of-interests for suspicious areas were manually drawn and evaluated for contrast-enhancement behavior by plotting intensity courses against time. Sensitivity and specificity with a 95% confidence interval and the negative predictive value and positive predictive value were calculated. Diagnostic accuracy was assessed. The histopathological diagnoses were used as a standard of reference. Fifty-five lesions were detected in 34 patients. All malignant breast lesions were identified correctly. There were 5 false-positive lesions. The sensitivity of contrast-enhanced magnetic resonance imaging of the breast at 3 T was 100%, with a 95% confidence interval (CI) of 90.6% to 100%. The specificity was 72.2%, with a 95% CI of 49.1% to 87.5%. The positive predictive value was 0.88 and the negative predictive value was 1. Diagnostic accuracy was 91% with a 95% CI of 80.4% to 96.1%. Our prospective study demonstrates that the presented 3 Tesla MR imaging protocol, comprising both high temporal and high spatial resolution, enables accurate detection and assessment of breast lesions.